Late presentation of HIV disease and its associated factors among newly diagnosed patients before and after abolition of a government policy of mass mandatory screening

Journal of Infection

Volumn 63, Issue 1, 2011, Pages 60-65

  Choe, Pyoeng Gyun ^a   Park, Wan Beom ^a   Song, Jin Su ^a   Kim, Nak Hyun ^a   Park, Jin Yong ^a   Song, Kyoung Ho ^a   Park, Sang Won ^a   Kim, Hong Bin ^a   Kim, Nam Joong ^a   Oh, Myoung don ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

AIDS; HIV; Late presentation; Risk factors; Screening

Indexed keywords

CD4 ANTIGEN;

ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GOVERNMENT; HEALTH CARE POLICY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOUTH KOREA; UNIVERSITY HOSPITAL; VENEREAL DISEASE REACTION TEST;

ADULT; AGE DISTRIBUTION; AGED; AIDS SERODIAGNOSIS; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH POLICY; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MANDATORY TESTING; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 79959612748     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.05.002     Document Type: Article

References (27)

1. Beckwith C.G., Flanigan T.P., del Rio C., Simmons E., Wing E.J., Carpenter C.C., et al. It is time to implement routine, not risk-based, HIV testing. Clin Infect Dis 2005, 40(7):1037-1040.
2. Althoff K.N., Gange S.J., Klein M.B., Brooks J.T., Hogg R.S., Bosch R.J., et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis 2010, 50(11):1512-1520.
3. Phillips A., Pezzotti P. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS 2004, 18(1):51-58.
4. Egger M., May M., Chene G., Phillips A.N., Ledergerber B., Dabis F., et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002, 360(9327):119-129.
5. Krentz H.B., Auld M.C., Gill M.J. The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med 2004, 5(2):93-98.
6. Marks G., Crepaz N., Senterfitt J.W., Janssen R.S. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005, 39(4):446-453.
7. Oh M.D., Choe K. Epidemiology of HIV infection in the Republic of Korea. J Korean Med Sci 1999, 14(5):469-474.
8. Cho B. HIV/AIDS policy in South Korea. Internatioal Stud Educ 2008, 9:37-39.
9. Kee M.K., Lee J.H., Chu C., Lee E.J., Kim S.S. Characteristics of HIV seroprevalence of visitors to public health centers under the national HIV surveillance system in Korea: cross sectional study. BMC Public Health 2009, 9:123.
10. Kee M.K., Lee J.H., Kim E.J., Lee J., Nam J.G., Yoo B.H., et al. Improvement in survival among HIV-infected individuals in the Republic of Korea:need for an early HIV diagnosis. BMC Infect Dis 2009, 9:128.
11. Castilla J., Sobrino P., De La Fuente L., Noguer I., Guerra L., Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002, 16(14):1945-1951.
12. Late versus early testing of HIV-16 Sites, United States, 2000-2003. MMWR Morb Mortal Wkly Rep 2003, 52(25):581-586. Centers for Disease Control and Prevention.
13. Klein D., Hurley L.B., Merrill D., Quesenberry C.P. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr 2003, 32(2):143-152.
14. Sabin C.A., Smith C.J., Gumley H., Murphy G., Lampe F.C., Phillips A.N., et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 2004, 18(16):2145-2151.
15. Brannstrom J., Akerlund B., Arneborn M., Blaxhult A., Giesecke J. Patients unaware of their HIV infection until AIDS diagnosis in Sweden 1996-2002-a remaining problem in the highly active antiretroviral therapy era. Int J STD AIDS 2005, 16(10):702-706.
16. Sullivan A.K., Curtis H., Sabin C.A., Johnson M.A. Newly diagnosed HIV infections: review in UK and Ireland. BMJ 2005, 330(7503):1301-1302.
17. Delpierre C., Dray-Spira R., Cuzin L., Marchou B., Massip P., Lang T., et al. Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS 2007, 18(5):312-317.
18. Borghi V., Girardi E., Bellelli S., Angeletti C., Mussini C., Porter K., et al. Late presenters in an HIV surveillance system in Italy during the period 1992-2006. J Acquir Immune Defic Syndr 2008, 49(3):282-286.
19. Oh M.D., Park S.W., Kim H.B., Kim U.S., Kim N.J., Choi H.J., et al. Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea. Clin Infect Dis 1999, 29(6):1524-1528.
20. Korea Centers for Disease Control. KCDC public health Weakly Report. [accessed 10.01.11] available at: http://www.cdc.go.kr/phwr.
21. Girardi E., Sabin C.A., Monforte A.D. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007, 46(Suppl. 1):S3-S8.
22. Pratt G., Gascoyne K., Cunningham K., Tunbridge A. Human immunodeficiency virus (HIV) in older people. Age Ageing 2010, 39(3):289-294.
23. Smith R.D., Delpech V.C., Brown A.E., Rice B.D. HIV transmission and high rates of late diagnoses among adults aged 50 years and over. AIDS 2010, 24(13):2109-2115.
24. Lohse N., Hansen A.B., Pedersen G., Kronborg G., Gerstoft J., Sorensen H.T., et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007, 146(2):87-95.
25. Sanders G.D., Bayoumi A.M., Sundaram V., Bilir S.P., Neukermans C.P., Rydzak C.E., et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 2005, 352(6):570-585.
26. Paltiel A.D., Weinstein M.C., Kimmel A.D., Seage G.R., Losina E., Zhang H., et al. Expanded screening for HIV in the United States-an analysis of cost-effectiveness. N Engl J Med 2005, 352(6):586-595.
27. Deblonde J., De Koker P., Hamers F.F., Fontaine J., Luchters S., Temmerman M. Barriers to HIV testing in Europe: a systematic review. Eur J Public Health 2010, 20(4):422-432.